Gynecologic Cancer News

Nearly seven in 10 premature cancer-related deaths among women could have been avoided through primary prevention, early detection or suitable access to cancer care, according to a report.

Researchers from City of Hope have detailed results of preclinical studies designed to optimize the durability of chimeric antigen receptor T cells for advanced ovarian cancer.

  Healio spoke to Emma Rossi, MD, gynecological oncologist at Duke Cancer Center, about combining different therapeutic modalities for advanced endometrial cancer.

  Healio spoke to Emma Rossi, MD, gynecological oncologist at Duke Cancer Center, about current and emerging prognostic biomarkers of endometrial cancer.

  Healio spoke to Emma Rossi, MD, gynecological oncologist at Duke Cancer Center, about treatment options for advanced recurrent endometrial cancer.

  Healio spoke to Emma Rossi, MD, gynecological oncologist at Duke Cancer Center, about recent advancements in endometrial cancer.

The FDA announced several regulatory actions.

Because ovarian cancer is one of the more difficult cancers to diagnose, it is important for health care providers and women to understand how symptoms present, how to mitigate risk and how to prevent disease progression.

Patients who have been hospitalized with systemic lupus erythematous demonstrate an increased risk for multiple cancer subtypes, as well as an increased risk for 5-year mortality after cancer development, according to data.

The addition of tumor-treating fields to chemotherapy did not prolong survival for women with platinum-resistant ovarian cancer, according to the device’s manufacturer.